Basics Precigen, Inc. IPO Date: August 9, 2013 Sector: Healthcare Industry: Biotech Market Cap: $416.2M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 4.26% Avg Daily Range (30 D): $0.05 | 3.23% Avg Daily Range (90 D): $0.07 | 4.47% Institutional Daily Volume Avg Daily Volume: 1.22M Avg Daily Volume (30 D): 1.4M Avg Daily Volume (90 D): 1.54M Trade Size Avg Trade Size (Sh.): 199 Avg Trade Size (Sh.) (30 D): 248 Avg Trade Size (Sh.) (90 D): 242 Institutional Trades Total Inst.Trades: 324 Avg Inst. Trade: $1.52M Avg Inst. Trade (30 D): $.99M Avg Inst. Trade (90 D): $.78M Avg Inst. Trade Volume: .33M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.57M Avg Closing Trade (30 D): $.51M Avg Closing Trade (90 D): $.68M Avg Closing Volume: 342.45K         News Dec 30, 2024 @ 5:31 PM Precigen Soars: Biologics License Application Subm... Source: Lekha Gupta Jun 3, 2024 @ 5:00 PM 6 Analysts Assess Precigen: What You Need To Know Source: Benzinga Insights Jun 2, 2024 @ 10:49 AM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast May 14, 2024 @ 9:20 PM Precigen, Inc. (PGEN) Reports Q1 Loss, Misses Reve... Source: Zacks Equity Research May 13, 2024 @ 9:10 PM Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.56 $-.18 $-.06 Diluted EPS $-.56 $-.18 $-.06 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -156.65M $ -54.15M $ -19.73M Operating Income / Loss $ $ $ Cost of Revenue $ $ $ Net Cash Flow $ -1.85M $ -23.46M $ 4.79M PE Ratio